Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2000 Oct;76(5):335–341. doi: 10.1136/sti.76.5.335

AIDS related systemic non-Hodgkin's lymphoma

T Powles 1, G Matthews 1, M Bower 1
PMCID: PMC1744226  PMID: 11141847

Abstract

Objective: To review the current literature on HIV associated non-Hodgkin's lymphoma.

Methods: A comprehensive Medline/Pubmed search of articles pertaining to HIV associated non-Hodgkin's lymphoma as well as personal experience from the treatment of over 200 patients at the Chelsea and Westminster Hospital, one of the largest centres for the management of HIV disease in Europe.

Conclusion: High grade B cell non-Hodgkin's lymphoma is the second commonest tumour affecting people with HIV. The incidence of this tumour is not declining following the introduction of highly active antiretroviral therapy. Chemotherapy has been employed with modest success in this group of patients; however, the prognosis remains worse than for immunocompetent patients. Advances in molecular genetics and virology have led to a greater understanding of the biology of these tumours. However, these advances have yet to be translated into improvements in the clinical management of patients with AIDS associated non-Hodgkin's lymphoma.

Key Words: AIDS; HIV; non-Hodgkin's lymphoma

Full Text

The Full Text of this article is available as a PDF (102.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beral V., Peterman T., Berkelman R., Jaffe H. AIDS-associated non-Hodgkin lymphoma. Lancet. 1991 Apr 6;337(8745):805–809. doi: 10.1016/0140-6736(91)92513-2. [DOI] [PubMed] [Google Scholar]
  2. Bloomfield C. D. Prognostic factors for selecting curative therapy for adult acute myeloid leukemia. Leukemia. 1992 Nov;6 (Suppl 4):65–67. [PubMed] [Google Scholar]
  3. Buchbinder S. P., Holmberg S. D., Scheer S., Colfax G., O'Malley P., Vittinghoff E. Combination antiretroviral therapy and incidence of AIDS-related malignancies. J Acquir Immune Defic Syndr. 1999 Aug 1;21 (Suppl 1):S23–S26. [PubMed] [Google Scholar]
  4. Carbone A., Dolcetti R., Gloghini A., Maestro R., Vaccher E., di Luca D., Tirelli U., Boiocchi M. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study. Hum Pathol. 1996 Feb;27(2):133–146. doi: 10.1016/s0046-8177(96)90366-4. [DOI] [PubMed] [Google Scholar]
  5. Cesarman E., Chang Y., Moore P. S., Said J. W., Knowles D. M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995 May 4;332(18):1186–1191. doi: 10.1056/NEJM199505043321802. [DOI] [PubMed] [Google Scholar]
  6. Chaganti R. S., Jhanwar S. C., Koziner B., Arlin Z., Mertelsmann R., Clarkson B. D. Specific translocations characterize Burkitt's-like lymphoma of homosexual men with the acquired immunodeficiency syndrome. Blood. 1983 Jun;61(6):1265–1268. [PubMed] [Google Scholar]
  7. Dean M., Carrington M., Winkler C., Huttley G. A., Smith M. W., Allikmets R., Goedert J. J., Buchbinder S. P., Vittinghoff E., Gomperts E. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 1996 Sep 27;273(5283):1856–1862. doi: 10.1126/science.273.5283.1856. [DOI] [PubMed] [Google Scholar]
  8. Dean M., Jacobson L. P., McFarlane G., Margolick J. B., Jenkins F. J., Howard O. M., Dong H. F., Goedert J. J., Buchbinder S., Gomperts E. Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation. Cancer Res. 1999 Aug 1;59(15):3561–3564. [PubMed] [Google Scholar]
  9. Dupin N., Diss T. L., Kellam P., Tulliez M., Du M. Q., Sicard D., Weiss R. A., Isaacson P. G., Boshoff C. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000 Feb 15;95(4):1406–1412. [PubMed] [Google Scholar]
  10. Emilie D., Coumbaras J., Raphael M., Devergne O., Delecluse H. J., Gisselbrecht C., Michiels J. F., Van Damme J., Taga T., Kishimoto T. Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients. Blood. 1992 Jul 15;80(2):498–504. [PubMed] [Google Scholar]
  11. Franceschi S., Dal Maso L., La Vecchia C. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms. Int J Cancer. 1999 Nov 12;83(4):481–485. doi: 10.1002/(sici)1097-0215(19991112)83:4<481::aid-ijc8>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  12. Gaidano G., Capello D., Gloghini A., Pastore C., Migliazza A., Quattrone S., Savinelli F., Buonaiuto D., Cilia A. M., Perin T. BCL-6 in aids-related lymphomas: pathogenetic and histogenetic implications. Leuk Lymphoma. 1998 Sep;31(1-2):39–46. doi: 10.3109/10428199809057583. [DOI] [PubMed] [Google Scholar]
  13. Gaidano G., Carbone A., Dalla-Favera R. Pathogenesis of AIDS-related lymphomas: molecular and histogenetic heterogeneity. Am J Pathol. 1998 Mar;152(3):623–630. [PMC free article] [PubMed] [Google Scholar]
  14. Gaidano G., Carbone A., Pastore C., Capello D., Migliazza A., Gloghini A., Roncella S., Ferrarini M., Saglio G., Dalla-Favera R. Frequent mutation of the 5' noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood. 1997 May 15;89(10):3755–3762. [PubMed] [Google Scholar]
  15. Gaidano G., Lo Coco F., Ye B. H., Shibata D., Levine A. M., Knowles D. M., Dalla-Favera R. Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype. Blood. 1994 Jul 15;84(2):397–402. [PubMed] [Google Scholar]
  16. Gisselbrecht C., Oksenhendler E., Tirelli U., Lepage E., Gabarre J., Farcet J. P., Gastaldi R., Coiffier B., Thyss A., Raphael M. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group. Am J Med. 1993 Aug;95(2):188–196. doi: 10.1016/0002-9343(93)90259-r. [DOI] [PubMed] [Google Scholar]
  17. Goedert J. J., Coté T. R., Virgo P., Scoppa S. M., Kingma D. W., Gail M. H., Jaffe E. S., Biggar R. J. Spectrum of AIDS-associated malignant disorders. Lancet. 1998 Jun 20;351(9119):1833–1839. doi: 10.1016/s0140-6736(97)09028-4. [DOI] [PubMed] [Google Scholar]
  18. Herndier B. G., Shiramizu B. T., Jewett N. E., Aldape K. D., Reyes G. R., McGrath M. S. Acquired immunodeficiency syndrome-associated T-cell lymphoma: evidence for human immunodeficiency virus type 1-associated T-cell transformation. Blood. 1992 Apr 1;79(7):1768–1774. [PubMed] [Google Scholar]
  19. Ioachim H. L., Dorsett B., Cronin W., Maya M., Wahl S. Acquired immunodeficiency syndrome-associated lymphomas: clinical, pathologic, immunologic, and viral characteristics of 111 cases. Hum Pathol. 1991 Jul;22(7):659–673. doi: 10.1016/0046-8177(91)90288-z. [DOI] [PubMed] [Google Scholar]
  20. Kaplan L. D., Abrams D. I., Feigal E., McGrath M., Kahn J., Neville P., Ziegler J., Volberding P. A. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA. 1989 Feb 3;261(5):719–724. [PubMed] [Google Scholar]
  21. Kaplan L. D., Straus D. J., Testa M. A., Von Roenn J., Dezube B. J., Cooley T. P., Herndier B., Northfelt D. W., Huang J., Tulpule A. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med. 1997 Jun 5;336(23):1641–1648. doi: 10.1056/NEJM199706053362304. [DOI] [PubMed] [Google Scholar]
  22. Kersten M. J., Van Gorp J., Pals S. T., Boon F., Van Oers M. H. Expression of Epstein-Barr virus latent genes and adhesion molecules in AIDS-related non-Hodgkin's lymphomas: correlation with histology and CD4-cell number. Leuk Lymphoma. 1998 Aug;30(5-6):515–524. doi: 10.3109/10428199809057564. [DOI] [PubMed] [Google Scholar]
  23. Knowles D. M., Chamulak G. A., Subar M., Burke J. S., Dugan M., Wernz J., Slywotzky C., Pelicci G., Dalla-Favera R., Raphael B. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med. 1988 May;108(5):744–753. doi: 10.7326/0003-4819-108-5-744. [DOI] [PubMed] [Google Scholar]
  24. Ledergerber B., Telenti A., Egger M. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study. BMJ. 1999 Jul 3;319(7201):23–24. doi: 10.1136/bmj.319.7201.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Levine A. M. Acquired immunodeficiency syndrome-related lymphoma. Blood. 1992 Jul 1;80(1):8–20. [PubMed] [Google Scholar]
  26. Levine A. M., Sullivan-Halley J., Pike M. C., Rarick M. U., Loureiro C., Bernstein-Singer M., Willson E., Brynes R., Parker J., Rasheed S. Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer. 1991 Dec 1;68(11):2466–2472. doi: 10.1002/1097-0142(19911201)68:11<2466::aid-cncr2820681124>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  27. Levine A. M., Wernz J. C., Kaplan L., Rodman N., Cohen P., Metroka C., Bennett J. M., Rarick M. U., Walsh C., Kahn J. Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial. JAMA. 1991 Jul 3;266(1):84–88. [PubMed] [Google Scholar]
  28. Liu R., Paxton W. A., Choe S., Ceradini D., Martin S. R., Horuk R., MacDonald M. E., Stuhlmann H., Koup R. A., Landau N. R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 1996 Aug 9;86(3):367–377. doi: 10.1016/s0092-8674(00)80110-5. [DOI] [PubMed] [Google Scholar]
  29. Lowenthal D. A., Straus D. J., Campbell S. W., Gold J. W., Clarkson B. D., Koziner B. AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer. 1988 Jun 1;61(11):2325–2337. doi: 10.1002/1097-0142(19880601)61:11<2325::aid-cncr2820611130>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  30. MacMahon E. M., Glass J. D., Hayward S. D., Mann R. B., Becker P. S., Charache P., McArthur J. C., Ambinder R. F. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet. 1991 Oct 19;338(8773):969–973. doi: 10.1016/0140-6736(91)91837-k. [DOI] [PubMed] [Google Scholar]
  31. Masood R., Zhang Y., Bond M. W., Scadden D. T., Moudgil T., Law R. E., Kaplan M. H., Jung B., Espina B. M., Lunardi-Iskandar Y. Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. Blood. 1995 Jun 15;85(12):3423–3430. [PubMed] [Google Scholar]
  32. Mocroft A., Vella S., Benfield T. L., Chiesi A., Miller V., Gargalianos P., d'Arminio Monforte A., Yust I., Bruun J. N., Phillips A. N. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet. 1998 Nov 28;352(9142):1725–1730. doi: 10.1016/s0140-6736(98)03201-2. [DOI] [PubMed] [Google Scholar]
  33. Nakajima K., Martínez-Maza O., Hirano T., Breen E. C., Nishanian P. G., Salazar-Gonzalez J. F., Fahey J. L., Kishimoto T. Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J Immunol. 1989 Jan 15;142(2):531–536. [PubMed] [Google Scholar]
  34. Obrams G. I., Grufferman S. Epidemiology of HIV associated non-Hodgkin lymphoma. Cancer Surv. 1991;10:91–102. [PubMed] [Google Scholar]
  35. Ockenga J., Tillmann H. L., Trautwein C., Stoll M., Manns M. P., Schmidt R. E. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol. 1997 Jul;27(1):18–24. doi: 10.1016/s0168-8278(97)80274-7. [DOI] [PubMed] [Google Scholar]
  36. Oksenhendler E., Duarte M., Soulier J., Cacoub P., Welker Y., Cadranel J., Cazals-Hatem D., Autran B., Clauvel J. P., Raphael M. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS. 1996 Jan;10(1):61–67. [PubMed] [Google Scholar]
  37. Palella F. J., Jr, Delaney K. M., Moorman A. C., Loveless M. O., Fuhrer J., Satten G. A., Aschman D. J., Holmberg S. D. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998 Mar 26;338(13):853–860. doi: 10.1056/NEJM199803263381301. [DOI] [PubMed] [Google Scholar]
  38. Pastore C., Gaidano G., Ghia P., Fassone L., Cilia A. M., Gloghini A., Capello D., Buonaiuto D., Gonella S., Roncella S. Patterns of cytokine expression in AIDS-related non-Hodgkin's lymphoma. Br J Haematol. 1998 Oct;103(1):143–149. doi: 10.1046/j.1365-2141.1998.00927.x. [DOI] [PubMed] [Google Scholar]
  39. Penn I. Cancers complicating organ transplantation. N Engl J Med. 1990 Dec 20;323(25):1767–1769. doi: 10.1056/NEJM199012203232510. [DOI] [PubMed] [Google Scholar]
  40. Peters B. S., Beck E. J., Coleman D. G., Wadsworth M. J., McGuinness O., Harris J. R., Pinching A. J. Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. BMJ. 1991 Jan 26;302(6770):203–207. doi: 10.1136/bmj.302.6770.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Petruckevitch A., Del Amo J., Phillips A. N., Johnson A. M., Stephenson J., Desmond N., Hanscheid T., Low N., Newell A., Obasi A. Disease progression and survival following specific AIDS-defining conditions: a retrospective cohort study of 2048 HIV-infected persons in London. AIDS. 1998 Jun 18;12(9):1007–1013. doi: 10.1097/00002030-199809000-00006. [DOI] [PubMed] [Google Scholar]
  42. Rabkin C. S., Testa M. A., Huang J., Von Roenn J. H. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants. J Acquir Immune Defic Syndr. 1999 Aug 1;21 (Suppl 1):S31–S33. [PubMed] [Google Scholar]
  43. Rabkin C. S., Yang Q., Goedert J. J., Nguyen G., Mitsuya H., Sei S. Chemokine and chemokine receptor gene variants and risk of non-Hodgkin's lymphoma in human immunodeficiency virus-1-infected individuals. Blood. 1999 Mar 15;93(6):1838–1842. [PubMed] [Google Scholar]
  44. Remick S. C., McSharry J. J., Wolf B. C., Blanchard C. G., Eastman A. Y., Wagner H., Portuese E., Wighton T., Powell D., Pearce T. Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin's lymphoma. J Clin Oncol. 1993 Sep;11(9):1691–1702. doi: 10.1200/JCO.1993.11.9.1691. [DOI] [PubMed] [Google Scholar]
  45. Roithmann S., Toledano M., Tourani J. M., Raphael M., Gentilini M., Gastaut J. A., Armengaud M., Morlat P., Tilly H., Dupont B. HIV-associated non-Hodgkin's lymphomas: clinical characteristics and outcome. The experience of the French Registry of HIV-associated tumors. Ann Oncol. 1991 Apr;2(4):289–295. doi: 10.1093/oxfordjournals.annonc.a057938. [DOI] [PubMed] [Google Scholar]
  46. Roithmann S., Tourani J. M., Andrieu J. M. AIDS-associated non-Hodgkin lymphoma. Lancet. 1991 Oct 5;338(8771):884–885. doi: 10.1016/0140-6736(91)91537-5. [DOI] [PubMed] [Google Scholar]
  47. Samson M., Libert F., Doranz B. J., Rucker J., Liesnard C., Farber C. M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996 Aug 22;382(6593):722–725. doi: 10.1038/382722a0. [DOI] [PubMed] [Google Scholar]
  48. Scadden D. T., Schenkein D. P., Bernstein Z., Luskey B., Doweiko J., Tulpule A., Levine A. M. Immunotoxin combined with chemotherapy for patients with AIDS-related non-Hodgkin's lymphoma. Cancer. 1998 Dec 15;83(12):2580–2587. doi: 10.1002/(sici)1097-0142(19981215)83:12<2580::aid-cncr25>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  49. Schnittman S. M., Lane H. C., Higgins S. E., Folks T., Fauci A. S. Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science. 1986 Sep 5;233(4768):1084–1086. doi: 10.1126/science.3016902. [DOI] [PubMed] [Google Scholar]
  50. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., d'Agay M. F., Clauvel J. P., Raphael M., Degos L. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 1995 Aug 15;86(4):1276–1280. [PubMed] [Google Scholar]
  51. Sparano J. A., Wiernik P. H., Hu X., Sarta C., Henry D. H., Ratech H. Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma. Med Oncol. 1998 Apr;15(1):50–57. doi: 10.1007/BF02787345. [DOI] [PubMed] [Google Scholar]
  52. Sparano J. A., Wiernik P. H., Hu X., Sarta C., Schwartz E. L., Soeiro R., Henry D. H., Mason B., Ratech H., Dutcher J. P. Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma. J Clin Oncol. 1996 Nov;14(11):3026–3035. doi: 10.1200/JCO.1996.14.11.3026. [DOI] [PubMed] [Google Scholar]
  53. Straus D. J., Huang J., Testa M. A., Levine A. M., Kaplan L. D. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases. J Clin Oncol. 1998 Nov;16(11):3601–3606. doi: 10.1200/JCO.1998.16.11.3601. [DOI] [PubMed] [Google Scholar]
  54. Subar M., Neri A., Inghirami G., Knowles D. M., Dalla-Favera R. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood. 1988 Aug;72(2):667–671. [PubMed] [Google Scholar]
  55. Tirelli U., Errante D., Spina M., Vaccher E., Serraino D., Boiocchi M., Gloghini A., Carbone A. Long-term survival of patients with HIV-related systemic non-Hodgkin's lymphomas. Hematol Oncol. 1996 Mar;14(1):7–15. doi: 10.1002/(SICI)1099-1069(199603)14:1<7::AID-HON556>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  56. Vaccher E., Tirelli U., Spina M., Talamini R., Errante D., Simonelli C., Carbone A. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients. J Clin Oncol. 1996 Aug;14(8):2217–2223. doi: 10.1200/JCO.1996.14.8.2217. [DOI] [PubMed] [Google Scholar]
  57. Ziegler J. L., Beckstead J. A., Volberding P. A., Abrams D. I., Levine A. M., Lukes R. J., Gill P. S., Burkes R. L., Meyer P. R., Metroka C. E. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med. 1984 Aug 30;311(9):565–570. doi: 10.1056/NEJM198408303110904. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES